[Long-term observations for Vi-antibody formation in patients following typhoid fever, treated with Vi-antigen in combination with levomycetin].
D000328:Adult; D000917:Antibody Formation; D000941:Antigens; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D014435:Typhoid Fever / Q000188:drug therapy*
D000941:Antigens; D002701:Chloramphenicol
Otdalennye nabliudeniia za Vi-antiteloobrazovaniem u lits, perenesshikh briushnoĭ tif i lechennykh Vi-antigenom v sochetanii s levomitsetinom.